Showing 113–128 of 246 results
-
MYLOTARG (gemtuzumab ozogamicin) for injection, for intravenous use.
Read more -
MYOBLOC (rimabotulinumtoxinB) injection
Read more -
NGENLA (somatrogon-ghla) injection
Read more -
NINLARO (ixazomib) capsules, for oral use.
Read more -
NUBEQA (darolutamide) tablets, for oral use. Initial U.S. Approval: 2019
Read more -
NUCALA (mepolizumab) for injection, for subcutaneous use.
Read more -
NUPLAZID (pimavanserin) tablets, for oral use Initial U.S. Approval: 2016
Read more -
OCREVUS (ocrelizumab) injection, for intravenous use. Initial U.S. Approval: 2017
Read more -
ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use. Initial U.S. Approval: 2016
Read more -
OGSIVEO (nirogacestat) tablets
Read more -
OJEMDA (tovorafenib) tablets
Read more -
OJJAARA (momelotinib) tablets
Read more -
OMVOH (mirikizumab-mrkz) injection
Read more -
ONGENTYS (opicapone) capsules. Get Access In India
Read more -
ONIVYDE (irinotecan liposome injection), for intravenous use. Initial U.S. Approval: 1996
Read more -
ONTRUZANT (trastuzumab-dttb) for injection, for intravenous use
Read more
